Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease

Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease. Immune response to oxidized low-density lipoprotein (oxLDL) may modulate the process of atherogenesis and cardiovascular disease. We performed a prospective, observational cohort study in 249 patien...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2002-12, Vol.62 (6), p.2230-2237
Hauptverfasser:	Shoji, Tetsuo, Fukumoto, Mariko, Kimoto, Eiji, Shinohara, Kayo, Emoto, Masanori, Tahara, Hideki, Koyama, Hidenori, Ishimura, Eiji, Nakatani, Tatsuya, Miki, Takami, Tsujimoto, Yoshihiro, Tabata, Tsutomu, Nishizawa, Yoshiki
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged anti-oxLDL atherosclerosis Autoantibodies - blood Biological and medical sciences Cohort Studies Cross-Sectional Studies Female hemodialysis Humans Hyperlipidemias - immunology Hyperlipidemias - mortality Hypertension - immunology Hypertension - mortality immune response Kidney Failure, Chronic - immunology Kidney Failure, Chronic - mortality Lipoproteins, LDL - immunology Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure oxidized LDL Predictive Value of Tests Proportional Hazards Models Prospective Studies Renal failure Risk Factors uremia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!